Tags

Type your tag names separated by a space and hit enter

Potential new indication for ivabradine: treatment of a patient with congenital junctional ectopic tachycardia.
J Cardiovasc Electrophysiol 2013; 24(7):822-4JC

Abstract

Ivabradine is a new antiarrhythmic agent with direct inhibition of the pacemaker (If) current. It has been used extensively to decrease sinus rate in the treatment of cardiac failure, and also in a single case of atrial ectopic tachycardia in a child. Here we report the case of a 3-year-old girl with congenital junctional ectopic tachycardia (JET), resistant to conventional antiarrhythmic medications, who was successfully treated with ivabradine. We suggest that ivabradine can be an effective treatment for junctional automatic tachycardias and can be considered as a new line of therapy for this incessant form of tachycardia.

Authors+Show Affiliations

Department of Pediatric Cardiology, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.No affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

23373720

Citation

Al-Ghamdi, Saleh, et al. "Potential New Indication for Ivabradine: Treatment of a Patient With Congenital Junctional Ectopic Tachycardia." Journal of Cardiovascular Electrophysiology, vol. 24, no. 7, 2013, pp. 822-4.
Al-Ghamdi S, Al-Fayyadh MI, Hamilton RM. Potential new indication for ivabradine: treatment of a patient with congenital junctional ectopic tachycardia. J Cardiovasc Electrophysiol. 2013;24(7):822-4.
Al-Ghamdi, S., Al-Fayyadh, M. I., & Hamilton, R. M. (2013). Potential new indication for ivabradine: treatment of a patient with congenital junctional ectopic tachycardia. Journal of Cardiovascular Electrophysiology, 24(7), pp. 822-4. doi:10.1111/jce.12081.
Al-Ghamdi S, Al-Fayyadh MI, Hamilton RM. Potential New Indication for Ivabradine: Treatment of a Patient With Congenital Junctional Ectopic Tachycardia. J Cardiovasc Electrophysiol. 2013;24(7):822-4. PubMed PMID: 23373720.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Potential new indication for ivabradine: treatment of a patient with congenital junctional ectopic tachycardia. AU - Al-Ghamdi,Saleh, AU - Al-Fayyadh,Majid I, AU - Hamilton,Robert M, Y1 - 2013/02/01/ PY - 2012/12/03/received PY - 2012/12/17/revised PY - 2012/12/18/accepted PY - 2013/2/5/entrez PY - 2013/2/5/pubmed PY - 2013/11/19/medline KW - If current KW - heart failure KW - ivabradine KW - junctional ectopic tachycardia KW - pediatrics SP - 822 EP - 4 JF - Journal of cardiovascular electrophysiology JO - J. Cardiovasc. Electrophysiol. VL - 24 IS - 7 N2 - Ivabradine is a new antiarrhythmic agent with direct inhibition of the pacemaker (If) current. It has been used extensively to decrease sinus rate in the treatment of cardiac failure, and also in a single case of atrial ectopic tachycardia in a child. Here we report the case of a 3-year-old girl with congenital junctional ectopic tachycardia (JET), resistant to conventional antiarrhythmic medications, who was successfully treated with ivabradine. We suggest that ivabradine can be an effective treatment for junctional automatic tachycardias and can be considered as a new line of therapy for this incessant form of tachycardia. SN - 1540-8167 UR - https://www.unboundmedicine.com/medline/citation/23373720/Potential_new_indication_for_ivabradine:_treatment_of_a_patient_with_congenital_junctional_ectopic_tachycardia_ L2 - https://doi.org/10.1111/jce.12081 DB - PRIME DP - Unbound Medicine ER -